Synthetic Peptide Impurities: How They Show in HPLC and MS

Synthetic peptide impurities are the related substances that accompany a target peptide after synthesis, purification and storage. Because most differ from the target by a single residue, one protecting group or a few atoms, they behave similarly in chromatography and must be identified from a combination of retention behavior and mass data. This article groups the common classes by origin and describes how each typically appears in HPLC and MS results.

Synthetic peptide impurities from chain assembly

The repetitive coupling steps of solid-phase peptide synthesis are the largest source of related impurities.

Deletion sequences

A deletion forms when a coupling step is incomplete and the next residue attaches to the uncoupled chain. The product is missing one residue, and its mass is lower by exactly that residue mass, for example −57.02 Da for glycine or −113.08 Da for leucine or isoleucine. Deletions often elute very close to the target because the change in overall hydrophobicity is small, and a missing hydrophobic residue usually shifts retention slightly earlier.

Truncated sequences

Truncations are chains that stopped growing, often because unreacted amines were deliberately capped with acetic anhydride. Capped truncations carry an N-terminal acetyl group (+42.01 Da relative to the uncapped fragment) and are usually well separated from the full-length peptide, which is the reason capping is used.

Insertion sequences

Less commonly, a residue is added twice, for example when traces of free amino acid or premature Fmoc removal allow a double addition. The impurity is heavier by one residue mass.

Impurities from deprotection and cleavage

Incomplete side-chain deprotection

If acid-labile side-chain groups are not fully removed during cleavage, the product retains them. These species are more hydrophobic and usually elute after the main peak.

• tert-Butyl (tBu) on Ser, Thr, Tyr, Asp or Glu: +56.06 Da
• Trityl (Trt) on Cys, His, Asn or Gln: +242.11 Da
• Pbf on Arg: +252.08 Da
• Boc on Lys or Trp: +100.05 Da

Alkylation by carbocations

Cations released from protecting groups can alkylate tryptophan, tyrosine, methionine or cysteine if scavengers are insufficient. A tert-butylated Trp has the same +56 Da shift as a retained tBu group, so MS/MS fragment data may be needed to locate the modification.

Aspartimide and related products

During repeated exposure to piperidine in Fmoc chemistry, aspartic acid, particularly at Asp-Gly and Asp-Ser motifs, can cyclize to an aspartimide (−18.01 Da). The ring can reopen with piperidine to form piperidide adducts (+67.08 Da relative to the target) or with water to give a mixture of α- and β-aspartyl peptides. The β-aspartyl isomer has the same mass as the target and can be difficult to resolve chromatographically.

Impurities from oxidation and degradation

Some impurities form after synthesis, during handling and storage. Conditions that slow them are covered in our article on storage and stability of lyophilized peptides.

Oxidation

Methionine oxidizes readily to methionine sulfoxide (+15.995 Da). The sulfoxide is more polar and typically elutes earlier in reversed-phase HPLC; because it creates a new stereocenter, it can appear as two closely spaced peaks. Tryptophan oxidation gives +16 and +32 Da products, and free cysteines can form disulfide-linked dimers or, in multi-cysteine peptides, mispaired disulfides.

Deamidation

Asparagine, especially in Asn-Gly sequences, can deamidate through a succinimide intermediate (−17.03 Da) to give aspartyl and isoaspartyl products, each +0.984 Da relative to the target. Glutamine deamidates more slowly. In MS this shift is a challenge: it differs from the 13C isotope spacing of +1.003 Da by only 0.019 Da, so on a low-resolution instrument a deamidated species overlaps the isotope envelope of the parent. High resolving power or chromatographic separation before MS is needed for reliable quantitation.

Pyroglutamate formation

An N-terminal glutamine can cyclize to pyroglutamate with loss of ammonia (−17.03 Da). The product loses a positive charge at low pH and often shifts to longer retention.

Stereochemical impurities and aggregation

Racemization

Epimerization during amino acid activation produces a diastereomer with a single D-residue. Cysteine and histidine are the most susceptible. The mass is unchanged, so MS cannot detect it directly. Diastereomers may appear as a shoulder or a closely eluting peak in an optimized HPLC method, or may co-elute entirely. Chiral amino acid analysis after hydrolysis, for example with Marfey's reagent derivatization, is the usual confirmatory approach, keeping in mind that hydrolysis itself causes some background racemization.

Aggregation

Hydrophobic or β-sheet-prone sequences can self-associate. Aggregation does not create a new covalent species, but it can produce broad, tailing or late-eluting peaks, variable peak areas and carryover from one run to the next. Size-exclusion chromatography is the more suitable tool for measuring it. In MS, non-covalent dimers may appear as [2M+H]+; note that a doubly charged dimer, [2M+2H]2+, falls at the same m/z as the monomer [M+H]+ and can be distinguished only by its 0.5 isotope spacing.

Reading HPLC and MS data together

The table below summarizes typical signatures. Retention behavior is a general tendency in reversed-phase HPLC and depends on the sequence and method.

Impurity class	Monoisotopic shift	Typical RP-HPLC behavior	Detectable by intact MS?
Deletion	− residue mass	Close to main peak, often slightly earlier	Yes
Capped truncation	Fragment mass + 42.01	Usually well separated	Yes
Residual tBu / Trt / Pbf	+56.06 / +242.11 / +252.08	Later (more hydrophobic)	Yes
Aspartimide	−18.01	Close to main peak	Yes
β-Aspartyl isomer	0	Close or co-eluting	No
Met oxidation	+15.995	Earlier, sometimes as a doublet	Yes
Deamidation	+0.984	Close to main peak	Only with high resolution
Racemization	0	Shoulder or co-eluting	No
Aggregation	None (non-covalent)	Broad, tailing or late signals	Sometimes, as multimers

A practical workflow is to integrate the UV chromatogram for purity, as described in HPLC purity testing explained, then use LC-MS extracted ion chromatograms to assign each impurity peak by its mass shift. Intact mass alone confirms the main species, as discussed in mass spectrometry identity confirmation, but zero-mass-change impurities always require chromatographic or chiral methods.

Frequently asked questions

Which impurity is most common in synthetic peptides?

Deletion sequences are generally the most frequent class, because small inefficiencies in each coupling step accumulate over the length of the chain.

Why can't mass spectrometry detect every impurity?

Isomeric impurities such as diastereomers from racemization and β-aspartyl peptides have exactly the same mass as the target. They must be separated chromatographically or analyzed by chiral methods.

Does a high HPLC purity mean no oxidation has occurred?

Not necessarily. Oxidized forms usually separate from the main peak, but a method not optimized for them may co-elute some species, so MS data is a useful complement.

How is a +1 Da peak distinguished from the isotope peak?

With sufficient resolving power, deamidation (+0.984 Da) and the 13C isotope (+1.003 Da) appear as separate peaks. Otherwise, chromatographic separation of the deamidated species before MS is needed.

References

1. USP <621> Chromatography.
2. ICH Q2(R2). Validation of Analytical Procedures.
3. Isidro-Llobet, A.; Álvarez, M.; Albericio, F. Amino Acid-Protecting Groups. Chemical Reviews, 2009.
4. Chan, W. C.; White, P. D. (eds.). Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press.